Amsterdam, 9 - 10 October 2024

Schedule

Create your personal agenda –check the favourite icon

Oct 97:30
Conference pass

Exhibitor Badge Collection

Keynotes

Exhibitor badge collection

Oct 98:00
Conference pass

Registration & Networking Meetings

Keynotes

Registration & Networking Meetings

Oct 99:00
Conference pass

Keynote presentation

Keynotes
Serban Ghiorghiu, Chief Safety Officer, AstraZeneca
Oct 99:20
Conference pass

Disruption in safety systems: cutting through GenAI hype to generate true ROI

Keynotes
Aman Wasan, Chief Executive Officer, ArisGlobal LLC
Oct 99:40
Conference pass

Enhancing medicines safety through external databases and artificial intelligence

Keynotes
Felix Arellano, Global Head of Pharmacovigilance and Drug Safety, Roche
Oct 910:00
Conference pass

Session Reserved for Parexel

Keynotes

Session Reserved for Parexel

Oct 910:20
Conference pass

Regulatory and Drug Safety: Two key partners in a formidable journey

Keynotes
Oct 910:40
Conference pass

The future of pharmacovigilance: trends for 2025 and beyond

Keynotes

Session Reserved for IQVIA

Updesh Dosanjh, Practice Lead Safety Technology, IQVIA
Oct 911:00
Conference pass

Morning Break

Keynotes

Morning Break

Oct 911:40
Conference pass

Chair's Remarks

AI & Automation
Peter De Veene, Associate Vice President, Global QPPV, MSD
Oct 911:40
Conference pass

Chair's Remarks - AXIAN

Risk Management

Chair's Remarks - AXIAN

Oct 911:40
Conference pass

Chair's Remarks

Signal Detection & Management
Oct 911:40
Conference pass
Oct 911:40
Conference pass

Chair's Remarks

Compliance
Gloria Bustos Busto, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare
Oct 911:40
Conference pass

Chair's Remarks

Case Processing
Garry Flounders, Global Pharmacovigilance Operations Lead, Biosimilars, Biogen
Oct 911:40
Conference pass

Chair's Remarks

Medical Devices
Sarah Freestone, Vice President, Head of Pharmacovigilance and Device Safety, UCB Pharma
Oct 911:40
Conference pass

Chair's Remarks

Patient Centricity
Alina Ioana Tudor, Global Head, Medical Evaluation and ICSR Review, Kyowa Kirin
Oct 911:40
Conference pass

Chair's Remarks

Digital Transformation
Claudia Pierleoni-Nielsen, Director, Global Safety Surveillance, LEO Pharma
Oct 911:40
Conference pass

Chair's Remarks

PV Outsourcing
Rita Lobatto, Vice President, Pharmacovigilance & QPPV, Pharming Group
Oct 911:45
Conference pass
Oct 911:45
Conference pass

Speaker presentation - AXIAN

Risk Management

Speaker presentation - AXIAN

Oct 911:45
Conference pass

Signal management in an immuno-oncology clinical trials

Signal Detection & Management

Speaker presentation

Ilana Frishman, Senior Director, Pharmacovigilance & Drug Safety, Compugen
Oct 911:45
Conference pass

Preparation for inspection readiness: working with multicultural stake-holders

Quality Assurance
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Oct 911:45
Conference pass

Medical reviews of ICSRs: case studies from FDA

Compliance
Riti Shah, Senior Medical Director, Pharmacovigilance, Chiesi
Oct 911:45
Conference pass

Innovations in case management processes: integrating systems with limited budgets

Case Processing
Matteo Barion, Digital Innovation & Technologies Unit Head, QPPV Office, Chiesi Farmaceutici SpA
Oct 911:45
Conference pass

Novel signal detection methods for medical devices

Medical Devices
Sarah Vaughan, Head of Vigilance Operations, MHRA
Oct 911:45
Conference pass

Pharmacovigilance systems in Africa: advancing global health goals

Patient Centricity
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Oct 911:45
Conference pass

Innovation ecosystems within pharmacovigilance

Digital Transformation
James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca
Oct 911:45
Conference pass

Overcoming hurdles in managing external suppliers in case processing

PV Outsourcing
Maximilian Jacobs, Head of Vendor Management, Pharmacovigilance, Bayer AG
Oct 912:05
Conference pass

Embracing change: the journey from manual to automated case workflows

AI & Automation

Sponsor Presentation - PharSafer

Graeme Ladds, CEO & Owner, PharSafer
Oct 912:05
Conference pass

Sponsor presentation - AXIAN

Risk Management

Sponsor presentation - AXIAN

Oct 912:05
Conference pass

Sponsor Presentation - Parexel

Signal Detection & Management

Sponsor Presentation - Parexel

Oct 912:05
Conference pass

Speaker Presentation - ProductLifeGroup

Quality Assurance

Speaker Presentation - ProductLifeGroup

Oct 912:05
Conference pass

EU AI Act and PV compliance

Compliance

Sponsor presentation - Sophos

Raghunandan Murthy, Director, Business Transformation and PV Consulting, Sophos IT Services
Oct 912:05
Conference pass

Sponsor presentation - Cognizant

Case Processing

Sponsor presentation - Cognizant

Oct 912:05
Conference pass

Sponsor presentation - explic8

Medical Devices

Sponsor presentation - explic8

Oct 912:05
Conference pass

Title TBC

Patient Centricity

Sponsor presentation

Paul Maruff, Chief Innovation Officer, Cogstate
Oct 912:05
Conference pass

Healthcare-grade AI: practical strategies for transforming PV workflows

Digital Transformation

Sponsor presentation - IQVIA

Marie Flanagan, Director, Offering Management, IQVIA
Updesh Dosanjh, Practice Lead Safety Technology, IQVIA
Oct 912:05
Conference pass

Future-proofing pharmacovigilance: governance, data collection and analyses for global success.

PV Outsourcing

Sponsor presentation - Qinecsa

Humaira Qureshi, President, Qinecsa Solutions
Oct 912:25
Conference pass

PharmaVigiPredict: A pilot, predictive surveillance model in pharmacovigilance using artificial intelligence

AI & Automation
Meenal Patwardhan, Vice President, Medical Safety Evaluation & Safety Data Sciences, AbbVie
Oct 912:25
Conference pass

Speaker presentation - AXIAN

Risk Management

Speaker presentation - AXIAN

Oct 912:25
Conference pass

Novel methods for signal assessment

Signal Detection & Management
Chris Bone, Director, Safety and Benefit Risk, Biogen
Oct 912:25
Conference pass

Regulatory challenges in quality assurance: producing guidance for the public sector

Quality Assurance
Marco Tuccori, Pharmacovigilance Manager, Coordinator & Co-Chair, University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board
Oct 912:25
Conference pass

Building compliance oversight in PV systems

Compliance
Irina Maria Ciubotaru, Vice President, Head of Global Drug Safety and Pharmacovigilance, EU & UK QPPV, ITM Isotope Technologies Munich SE
Oct 912:25
Conference pass

Establishing case processing and compliance in social media in small and medium sized enterprises

Case Processing
Oct 912:25
Conference pass

Changing legislation across geographies for medical devices

Medical Devices
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Oct 912:25
Conference pass

Benefit risk assessments for patients

Patient Centricity
Stéphanie Tcherny-Lessenot, Global Head, Benefit-Risk Evaluation, Sanofi
Oct 912:25
Conference pass

Assessment of digital health in post market safety – an industry and regulatory landscape

Digital Transformation
Oct 912:25
Conference pass

New models for outsourcing case management: working with ESPs to build processes

PV Outsourcing
Minhaj Obeidullah, Head, Compliance and Risk Management, Novartis
Oct 912:45
Conference pass

Sponsor presentation - Ultragenic

AI & Automation

Sponsor presentation - Ultragenic

Oct 912:45
Conference pass

Sponsor presentation - AXIAN

Risk Management

Sponsor presentation - AXIAN

Oct 912:45
Conference pass

Practical approaches in signal detection during clinical studies

Signal Detection & Management
John Fitzpatrick, Senior Pharmacovigilance Manager, ProPharma
Oct 912:45
Conference pass

Changing landscape of PV: strategies to win

Quality Assurance

Sponsor presentation - QPD Group

Belkis Lanza, Drug Safety Coordinator, QBD Group
Oct 912:45
Conference pass

A blueprint for optimizing pharmacovigilance for country affiliates

Compliance

Sponsor presentation - IQVIA

Barry Mulchrone, Head of Safety Science & Strategy Lifecycle Safety, IQVIA
Oct 912:45
Conference pass

Strategies for successfully scaling GenAI PV initiatives from Pilot to Production

Case Processing

Sponsor presentation - Indegene

Nikesh Shah, Vice President and Global Head, Drug Safety and Pharmacovigilance, Indegene
Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.
Oct 912:45
Conference pass

Sponsor presentation - Pinnaxis

Medical Devices

Sponsor presentation - Pinnaxis

Oct 912:45
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 912:45
Conference pass

Sponsor presentation - NNIT

Digital Transformation

Sponsor presentation - NNIT

Oct 912:45
Conference pass

Sponsor presentation - Insuvia

PV Outsourcing

Sponsor presentation - Insuvia

Oct 913:05
Conference pass

Applications and innovations of AI in signal management

AI & Automation
Philip Jones, Senior Director, Disease Area Cluster Lead, Inflammation & Immunology, Pfizer
Oct 913:05
Conference pass

Speaker presentation - AXIAN

Risk Management

Speaker presentation - AXIAN

Oct 913:05
Conference pass

Signal detection understanding similarities: medical devices, vaccines and drugs

Signal Detection & Management
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics
Oct 913:05
Conference pass

Building a delegation profile for QPPVs

Quality Assurance
Heike von Treichel, Senior Director, Deputy EU QPPV, Head of PV QMS and QPPV Office, Merck
Oct 913:05
Conference pass

SYNAPSE: A connective, comprehensive, compliance concept

Compliance
Oct 913:05
Conference pass

Integration of case processing in smaller pharmaceutical companies

Case Processing
Johanna Strandell, Director, Patient Safety, Camurus AB
Oct 913:05
Conference pass

Software as a medical device: SaMD

Medical Devices
Ben Kitchens, Associate Director, Medical Devices, Diagnostics Lead, Otsuka Pharmaceutical Companies (U.S.)
Oct 913:05
Conference pass

Driving patient centricity in pharmacovigilance at a country level

Patient Centricity
Yvonne Nanciu, Country Head, Pharmacovigilance, Deputy EU QPPV, Bayer
Oct 913:05
Conference pass

The future of the PV industry in the next 10 years

Digital Transformation
Oct 913:05
Conference pass

Transforming local safety roles

PV Outsourcing
Begum Benli Peker, Director, Head of Patient Safety Netherlands & EU Hub Lead, Bristol Myers Squibb
Oct 913:25
Conference pass

Lunch

Keynotes

Lunch

Oct 914:25
Conference pass

01 AI & Automation Panel – Innovating in automation: diverse perspectives across the PV industry

AI & Automation
Claudia Lehmann, Vice President, Head, Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Uwe Gudat, Chief Medical Officer, Biocon Biologics
Finn Larsen, Head, Technology and Data Management, Sandoz Patient Safety
Oct 914:25
Conference pass

02 Risk Management Panel – Benefit risk management and assessments: engaging patients

Risk Management
john solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi
Luiz Lima, Vice President, Head of Neuroscience, Global Patient Safety, Ipsen
Anna Pelnikevich, Director, Head of Benefit-Risk Management, Merck
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland
Sunita Dhar, Executive Medical Group Director, Clinical Safety, Genentech
Oct 914:25
Conference pass

03 Signal Detection & Management Panel – Safety related posts to agency websites and submissions excluding label updates

Signal Detection & Management
Willemijn Van Der Spuij, Executive Director, International Patient Safety, Bristol-Myers Squibb
Phillip Eichorn, Global Head of Drug Safety, Chiesi
Nayanika Rivankar, Signal Management Strategy Lead, Merck Group
Oct 914:25
Conference pass

04 Quality Assurance Panel – Behind the curtains of inspections: recent advances in GVP inspections

Quality Assurance
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Dominic Nguyen-Van-Tam, Senior Pharmacovigilance Inspector, MHRA
Oct 914:25
Conference pass

05 Compliance Panel – Global oversight for diverging regulations and business partners: harmonizing stakeholders

Compliance
Fabio Miceli, EU QPPV, Norgine
Michelle Motta Dardeno, Vice President, Head, Global Patient Safety, Aurinia
Teresa Saragoça, Technical Director and Head of Regulatory Affairs, Italfarmaco PT
Marco Colombati, PV Operations Manager, ITALFARMACO S.P.A.
Javed Iqbal, Senior Director Pharmacovigilance, Elanco
Oct 914:25
Conference pass

06 Compliance Panel – New challenges for PV inspection readiness: inspected and inspectors view point

Case Processing
Claire Longman, Expert Pharmacovigilance Inspector, MHRA
Zina Sadeq, Director, Regional PV and Alliance Management, Deputy UK QPPV, AMICUS THERAPEUTICS
Diane Halle, Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals
Oct 914:25
Conference pass

07 Medical Devices Panel - Different safety approaches between pharma, devices, and combination products

Medical Devices
Stella Lee, Independent PV Expert
Judy Barretto, Senior Director, Virology TA, Patient Safety, Gilead
Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)
Oct 914:25
Conference pass

08 Reserved Panel – EVERSANA

Patient Centricity

08 Reserved Panel – EVERSANA

Oct 914:25
Conference pass

09 Digital Transformation Panel - Managing digital health – what are the considerations when implementing digital health to advance safety?

Digital Transformation
James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca
Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency
Oct 914:25
Conference pass

10 Reserved Panel – Safeguard your safety technology investment

PV Outsourcing

10 Reserved Panel – ArisGlobal

Ann-Marie Orange, Chief Information Officer, ArisGlobal
Oct 915:20
Conference pass

Chair's Remarks

AI & Automation

Chair's Remarks

Oct 915:20
Conference pass

Chair's Remarks

Risk Management
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Oct 915:20
Conference pass
Oct 915:20
Conference pass

Chair's Remarks

Quality Assurance
Jutta Syha, Independent PV Expert, Independent PV Expert
Oct 915:20
Conference pass

Chair's Remarks

Compliance
Wasim Anwar, Vice President, Deputy QPPV, Novo Nordisk A/S
Oct 915:20
Conference pass

Chair's Remarks

Case Processing

Chair's Remarks

Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi
Oct 915:20
Conference pass

Chair's Remarks

Medical Devices

Chair's Remarks

Joan D'souza, Independent PV Expert
Oct 915:20
Conference pass
Oct 915:20
Conference pass

Chair's Remarks

Digital Transformation
Attila Oláh, Vice President, Head, Global Patient Safety, EU-QPPV, Gedeon Richter PLC
Oct 915:20
Conference pass

Chair's Remarks

PV Outsourcing
Emma Boulton, Director, Local Safety Operations, Mundipharma
Oct 915:25
Conference pass

Machine learning and emerging technologies in patient safety

AI & Automation
Sibel Guerler, Senior Director, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb
Oct 915:25
Conference pass

Procedure and RMP governance: challenges and solutions for the PV sector

Risk Management
Kristin Knalstad, Director, Risk Management, Patient Safety, Astrazeneca
Asa Mattsson, Senior Director, Patient Safety Risk Management, Process & Implementation, Astrazeneca
Oct 915:25
Conference pass

Integration of real-world data into signal management

Signal Detection & Management
Siva Kumar Buddha, Director, Pharmacovigilance, Head of Signals and Risk Management, Indegene Inc.
Oct 915:25
Conference pass

The changing landscape of PV inspections

Quality Assurance
Smruti Kothari, Associate Director, PV QA, Jazz Pharmaceuticals
Oct 915:25
Conference pass

Compliance metrics for vendors and partners in MENA region

Compliance
Mina G Awad, Pharmacovigilance Senior Manager and QPPV, Middle East, Kyowa Kirin International
Oct 915:25
Conference pass

Monitoring compliance in case processing

Case Processing
Katarzyna Gruchala, Director, PV Operations Global Submissions, Moderna
Oct 915:25
Conference pass

Integrating patient voices in risk minimization measures

Patient Centricity
Robert Massouh, Head, Risk Management and Benefit-Risk Evaluation, GSK
Oct 915:25
Conference pass

Continuing the innovation journey in Moderna: clinical trials and case processing

Digital Transformation
Olga Błaszczyk, Manager, Global Case Management, PV Operations, Moderna
Marta Bałuka, Manager, Global Case Management, PV Operations, Moderna
Oct 915:25
Conference pass

Different partners and providers for PV outsourcing

PV Outsourcing
Juri Hodisch, Head, Drug Safety, QPPV, AOP Health
Oct 915:45
Conference pass

Sponsor presentation - iVigee

AI & Automation

Sponsor presentation - iVigee

Oct 915:45
Conference pass

Developing risk management plans for cell and gene therapies - APCER Life Sciences

Risk Management

Developing risk management plans for cell and gene therapies - APCER Life Sciences

Oct 915:45
Conference pass

Sponsor presentation - ArisGlobal

Signal Detection & Management

Sponsor presentation - ArisGlobal

Oct 915:45
Conference pass

Sponsor presentation - RiverArk

Quality Assurance

Sponsor presentation - RiverArk

Oct 915:45
Conference pass

Sponsor presentation - Siro CLINPHARM

Compliance

Sponsor presentation - Siro CLINPHARM

Oct 915:45
Conference pass

Sponsor presentation

Case Processing

Sponsor presentation

Oct 915:45
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 915:45
Conference pass

Patient-centricity across the product lifecycle: not anymore a wish but a reality

Patient Centricity
Oct 915:45
Conference pass

Sponsor presentation - HCLTech

Digital Transformation

Sponsor presentation - HCLTech

Oct 915:45
Conference pass

Sponsor presentation - Eversana

PV Outsourcing

Sponsor presentation - Eversana

Oct 916:05
Conference pass

AI safety systems and analytics: innovations for mid-sized biotech companies

AI & Automation
Tarak Thakker, Director, Head of Safety Systems and Analytics, BeiGene
Oct 916:05
Conference pass

Variated control distribution systems for biosimilars: managing risk minimization

Risk Management
John Hart, Director, EEA & UK QPPV, Samsung Bioepis NL B.V
Oct 916:05
Conference pass

Safety management in phase 1 studies

Signal Detection & Management
Sutirtha Mukhopadhyay, Senior Associate Director, Senior Patient Safety Physician, Boehringer Ingelheim
Oct 916:05
Conference pass

PV audits: pitfalls for the oversight of distributors

Quality Assurance
Hadir Rostom, Independent PV Expert - Lecturer, Modern Sciences And Arts University
Oct 916:05
Conference pass

Training and mentoring compliance in pharmacovigilance: knowledge sharing to enhance global quality

Compliance
Ewa Malinowska, Associate Director, Global Pharmacovigilance Case Management, MSD
Iwona Piotrowska-Potapczyk, Associate Director, Global Pharmacovigilance Case Management, MSD
Oct 916:05
Conference pass

Optimizing case management for SMEs

Case Processing
Oct 916:05
Conference pass

Gaps in regulations for drug device combinations

Medical Devices
Joan D'souza, Independent PV Expert
Oct 916:05
Conference pass

Enhancing PV education across HCPs: Implementation of an online PV course for pharmacists in Romania - a joint initiative

Patient Centricity
Elena Cucu, Deputy EU QPPV, AbbVie
Oct 916:05
Conference pass

Challenges in using social media for pharmacovigilance

Digital Transformation
Oct 916:05
Conference pass

Transitions in PV outsourcing: case processing and safety databases

PV Outsourcing
Oct 916:25
Conference pass

Networking Break

Keynotes

Networking Break

Oct 917:05
Conference pass

Chair's Remarks

AI & Automation

Chair's Remarks

Oct 917:05
Conference pass

Chair's Remarks

Risk Management
Emanuel Lohrmann, Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals
Oct 917:05
Conference pass

Chair's Remarks

Signal Detection & Management
Leith Kwaan, QPPV, National Bioproducts Institute NPC
Oct 917:05
Conference pass

Chair's Remarks

Quality Assurance
ELENA KELLER, Director, PV, RA, Quality and Medical Operations, Local QPPV, Ipsen Pharma GmbH
Oct 917:05
Conference pass

Chair's Remarks

Compliance

Chair's Remarks

Magda Daudin, Director, Head of PV Operations and Compliance, Idorsia
Oct 917:05
Conference pass

Chair's Remarks

Case Processing

Chair's Remarks

Monika Kowalska, Director, Global Case Management, Moderna
Oct 917:05
Conference pass

Chair's Remarks

Medical Devices

Chair's Remarks

Oct 917:05
Conference pass
Oct 917:05
Conference pass

Chair's Remarks

Digital Transformation

Chair's Remarks

Camilla Hammerum, Vice President, Head of GPS TA Oncology, Ipsen
Oct 917:10
Conference pass

How to approach innovation with GenAI in patient safety

AI & Automation
Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB
Oct 917:10
Conference pass
Oct 917:10
Conference pass

Safety monitoring in clinical studies

Signal Detection & Management
Oct 917:10
Conference pass

Risk-based auditing, from planning to closure

Quality Assurance
Rebecca Webb, Senior Director, Safety, Vigilance and Medical Affairs QA, AbbVie
Oct 917:10
Conference pass

Being inclusive at a global level: ensuring compliance in Taiwan and Korea

Compliance
Ariane Stollenwerk, Director, Head of Central Europe & Asian Int. Markets, International PhV, UCB Pharma
Oct 917:10
Conference pass

Process mining to measure efficiencies following the implementation of advanced technologies

Case Processing
Oct 917:10
Conference pass

Finding common ground for combination products regarding vigilance

Medical Devices
Ronald Boumans, Independent Medical Devices Expert, EU Medical Devices Expert
Oct 917:10
Conference pass

Management of local PV regulation for global patient safety perspectives

Patient Centricity
Donald Puccio, Senior Director, Team Leader Oncology, Aggregate Reports, Pfizer
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Oct 917:10
Conference pass

iVigilance: aligning digital transformation and regulations with local LSRs

Digital Transformation
Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals
Oct 917:10
Conference pass

Outsourcing of strategic PV activities

PV Outsourcing
Conny Johansson, Alliance Management Lead, Roche
Oct 917:30
Conference pass

Sponsor presentation - Transperfect

AI & Automation

Sponsor presentation - Transperfect

Oct 917:30
Conference pass

Sponsor presentation

Risk Management

Sponsor presentation

Oct 917:30
Conference pass

Sponsor presentation

Signal Detection & Management

Sponsor presentation

Oct 917:30
Conference pass

Process audits - a mirror to compliance

Quality Assurance

Sponsor presentation

Milind Nadgouda, Director, Operations, RiverArk Limited
Oct 917:30
Conference pass

Sponsor presentation

Compliance

Sponsor presentation

Oct 917:30
Conference pass

Sponsor presentation

Case Processing

Sponsor presentation

Oct 917:30
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 917:30
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 917:30
Conference pass

PV SaaS movement – Expectations and key success factors

Digital Transformation
Mayank Bhandari, Co-Founder, Head, Global Consulting, Ultragenic Research & Technologies LLC
Fabrice Besle, Director, PV Database & Analytic Reporting, Ipsen
Oct 917:30
Conference pass

Sponsor presentation - ALWIS

PV Outsourcing

Sponsor presentation - ALWIS

Oct 917:50
Conference pass

Case studies for intelligent automation in PV

AI & Automation
Ranga Reddy, Head of Drug Safety Technologies, Former CSL Vifor
Oct 917:50
Conference pass

Development RMPs (dRMP): importance in clinical programmes

Risk Management
Claudia Pierleoni-Nielsen, Director, Global Safety Surveillance, LEO Pharma
Oct 917:50
Conference pass

Title TBC

Signal Detection & Management

Speaker presentation

Maria Chrzanowska, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Dominika Łukasz, Associate Director, Clinical Trial Safety Scientist, AstraZeneca
Oct 917:50
Conference pass

Inspection readiness & setting up quality management systems for cell & gene therapies

Quality Assurance

Speaker presentation

Kapil Bhutada, Senior Director, Quality and Compliance, Inozyme Pharma
Oct 917:50
Conference pass

Key performance indicators in a robust global PV system

Compliance
Tsambika Fuchs, Team Lead PV Intelligence and Performance Management, Merck Healthcare KGaA
Oct 917:50
Conference pass

Medium sized pharma perspectives for automations in case assessments

Case Processing
Oana Rad, Senior Safety Scientist, B Braun
Oct 917:50
Conference pass

The role of medical doctors in risk management

Medical Devices

Speaker presentation

Oct 917:50
Conference pass

Details matter – outsourcing and simplification considering local affiliate requirements

Patient Centricity

Speaker presentation

Ekaterina Edle von Dall'Armi, Deputy Local QPPV & Senior Medical Advisor Patient Safety, GSK
Oct 917:50
Conference pass

Turning the ambition into a roadmap to ensure quality, speed, consistency and flexibility

Digital Transformation
Yvonne Schäfer, Head of Patient Safety & Pharmacovigilance Systems Business Solutions, Boehringer Ingelheim International
Oct 917:50
Conference pass

QPPV oversight for local safety representatives outsourcing

PV Outsourcing
Anna Stahl, Deputy QPPV, BeiGene
Oct 918:10
Conference pass

Close of conference and drinks reception

Keynotes

Close of conference and drinks reception

Create your personal agenda –check the favourite icon

Oct 108:55
Conference pass

Chair's Remarks

Keynotes
Shaloo Pandhi, Global Head, Patient Safety, Sandoz
Oct 109:00
Conference pass

Session Reserved for Veeva

Keynotes

Session Reserved for Veeva

Oct 109:20
Conference pass
Oct 109:40
Conference pass

Session Reserved for RxLogix

Keynotes

Session Reserved for RxLogix

Oct 1010:00
Conference pass

Session Reserved for Cognizant

Keynotes

Session Reserved for Cognizant

Oct 1010:20
Conference pass

Keynote Panel Discussion - Empowering patients: advancing patient-centric approaches in pharmacovigilance

Keynotes
Avinash Kakade, Senior Vice President, Global Head of Pharmacovigilance, Dr. Reddy's Laboratories
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Karsten Lollike, Corporate Vice President, QPPV, Novo nordisk
Fabian Heisig, Senior Vice President, Head Global Drug Safety & QPPV, Grunenthal
Shaloo Pandhi, Global Head, Patient Safety, Sandoz
Oct 1011:00
Conference pass

Morning Break & Interactive Poster Sessions

Keynotes

Morning Break & Interactive Poster Sessions

Oct 1011:40
Conference pass

Chair's Remarks

Automation

Chair's Remarks

Teodora Perger, Senior Medical Director, Global Safety Physician, AstraZeneca
Oct 1011:40
Conference pass

Chair's Remarks

Artificial Intelligence
Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI
Oct 1011:40
Conference pass

Chair's Remarks

Risk Management
Frédérique Delannois, Executive Director, Safety Evaluation & Risk Management Head, Global Safety, Gsk
Oct 1011:40
Conference pass
Oct 1011:40
Conference pass

Chair's Remarks

Quality Assurance
Vivienne van de Walle, Medical Director, P.T. and R
Oct 1011:40
Conference pass

Chair's Remarks

Compliance
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Oct 1011:40
Conference pass

Chair's Remarks

Medical Devices
Maritess Esguerra, Senior PV Process Director for Safety Development and Processes, Genentech
Oct 1011:40
Conference pass
Oct 1011:40
Conference pass

Chair's Remarks

Digital Transformation

Chair's Remarks

Oct 1011:40
Conference pass

Chair's Remarks

PV Outsourcing
Amina Baljic, Senior Director, Head, PV Operations and PV Excellence, Grunenthal
Oct 1011:45
Conference pass

AI application and automation of a probabilistic tool to assess causality

Artificial Intelligence
Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV
Oct 1011:45
Conference pass

Hyper automation in pharmacovigilance - Unleash the power of automation through integrated and connected technologies

Automation
Oct 1011:45
Conference pass

Differing periodic reports and risk management plans for regulators

Risk Management
Dineke Eikelboom, Associate Director, Medical Safety, Pharmacovigilance, Astellas Pharma
Oct 1011:45
Conference pass

The role of AI in global signal detection

Signal Detection & Management
Oct 1011:45
Conference pass

Comparing and contrasting different types of PV audits

Quality Assurance
Ranjana Khanna, Global Director, GVP, QA, R&D Quality, BeiGene
Oct 1011:45
Conference pass

North American pharmacovigilance compliance requirements and inspection readiness

Compliance
Jaylaxmi Nalawade, Director, Pharmacovigilance and REMS, Lupin
Oct 1011:45
Conference pass

Medical safety R&D

Medical Devices
Richard Mayer, Senior Principal Engineer, Head of Medical Safety R&D, Johnson and Johnson
Oct 1011:45
Conference pass

Title TBC

Patient Centricity
Ercem Atillasoy, Chief Regulatory and Safety Officer, Jazz Pharmaceuticals
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Oct 1011:45
Conference pass

The patient drug safety paradigm in the 2030's

Digital Transformation
Fabio Lievano, Vice President, Safety Science, AbbVie
Oct 1011:45
Conference pass

Optimising outsourcing across affiliates and regions

PV Outsourcing
Majken Berghuis, Director, Pharmacovigilance, International Operations, Novo nordisk
Oct 1012:05
Conference pass

Applying GenAI in pharmacovigilance - Reserved for ArisGlobal

Automation

Sponsor presentation

Oct 1012:05
Conference pass

Sponsor presentation - Insife

Artificial Intelligence

Sponsor presentation - Insife

Oct 1012:05
Conference pass

Enhancing patient safety through comprehensive risk management plan oversight

Risk Management
Oct 1012:05
Conference pass

Automated and centralised approach to enhance signal detection and surveillance efficiency for SMEs

Signal Detection & Management

Sponsor presentation - PubHive Ltd

Maja Barac, Chief Executive Officer & EU QPPV, Pharmavigil
Raj Vaghela, Chief Executive Officer, PubHive Ltd.
Oct 1012:05
Conference pass

PV outsourcing - from industry to service provider, and back

Quality Assurance

Sponsor presentation

Martijn van de Leur, Chief Operating Officer PV/RA/MI, Biomapas
Oct 1012:05
Conference pass

Sponsor presentation

Compliance

Sponsor presentation

Oct 1012:05
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 1012:05
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 1012:05
Conference pass

Sponsor presentation

Digital Transformation

Sponsor presentation

Oct 1012:05
Conference pass

Best practices when outsourcing PV services at the local and regional level

PV Outsourcing
Alex Brenchat, Vice President, Local Pharmacovigilance Services, PharmaLex
Oct 1012:15
Conference pass

Effective management strategies for development safety update reports amid challenges and complexities

Risk Management
Mugdha Chopra, Co-Founder and Director, AWINSA Life Sciences
Oct 1012:25
Conference pass

Application of machine translations (MT) and AI technologies in end-to-end case processing

Automation
Achilleas Kalogirou, Lead, Office of Safety Operations, AbbVie
Oct 1012:25
Conference pass

Pharma Speaker - Insife

Artificial Intelligence

Pharma Speaker - Insife

Oct 1012:25
Conference pass

Contraception in clinical trials

Risk Management
Oct 1012:25
Conference pass

Safety management in cell and gene therapies

Signal Detection & Management
Asif Mahmood, Vice President, Medical Safety & Pharmacovigilance, AskBio
Céline Muffang, Associate Director, Medical Safety & Pharmacovigilance, AskBio
Oct 1012:25
Conference pass

The realms of audits and inspections

Quality Assurance
Erika Barbarosie, Associate Director, Compliance, Gilead Sciences
Oct 1012:25
Conference pass

PSMF innovations: using digital tools to build user friendly documents

Compliance
Maria Jose Reneses, Director, Deputy EU QPPV and Head of PSMF, Takeda
Oct 1012:25
Conference pass

New standards for clinical evaluations of medical devices: upcoming ISO standards

Medical Devices
Milos Stojkovic, Safety Process Director, Roche
Oct 1012:25
Conference pass

Monitoring patients in advance therapeutics

Patient Centricity
David Chonzi, Independent Pharma Physician, Independent PV Expert
Oct 1012:25
Conference pass

Open access platform to advance perinatal therapeutics

Digital Transformation
Oct 1012:25
Conference pass

From transition to transformation: improving quality and speed of delivery for patient safety

PV Outsourcing
Justin Joubert, Senior Director, Acquisitions, PV Agreements & Contract Liason, Gsk
Oct 1012:45
Conference pass

Medical literature monitoring: integrating local and global

Automation

Sponsor presentation

Nicole Baker, CEO, biologit
Oct 1012:45
Conference pass

Sponsor presentation - IQVIA

Artificial Intelligence

Sponsor presentation - IQVIA

Oct 1012:45
Conference pass

Sponsor presentation - Orbit by Feith Systems

Risk Management

Sponsor presentation - Orbit by Feith Systems

Oct 1012:45
Conference pass

Sponsor presentation - Soterius

Signal Detection & Management

Sponsor presentation - Soterius

Oct 1012:45
Conference pass

Sponsor presentation

Quality Assurance

Sponsor presentation

Oct 1012:45
Conference pass

The importance of good collaboration between different vendors to ensure compliance with the global/local regulations

Compliance

Sponsor presentation

Esther Aparicio, Manager, Pharmacovigilance, UBC
Myrto Ioannidi, Director, Pharmacovigilance, UBC
Oct 1012:45
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 1012:45
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 1012:45
Conference pass

Sponsor presentation

Digital Transformation

Sponsor presentation

Oct 1012:45
Conference pass

MDR: How integrated workflows can support your Clinical Evaluation Report (CER)

PV Outsourcing

Sponsor presentation

Oct 1013:05
Conference pass

Large language models for causality assessment

Artificial Intelligence
Maurizio Sessa, Associate Professor, Pharmacovigilance and Pharmacoepidemiology, University of Copenhagen
Oct 1013:05
Conference pass

Mobile applications and their uses in pharmacovigilance adverse event reporting

Automation
Elena Davison, Executive Director, Global Pharmacovigilance Informatics, Sunovion Pharmaceuticals
Oct 1013:05
Conference pass

Effectiveness of risk minimization measures in Europe

Risk Management
Maha Lakshmi Elluri, Global Safety Director, EEA/UK QPPV, Indivior Pharmaceuticals
Oct 1013:05
Conference pass

Signal detection for orphan diseases

Signal Detection & Management
Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma
Oct 1013:05
Conference pass

Inspection in gene therapies: different approaches and experiences

Quality Assurance
Elisabetta Di Martino, Director, GCP, GVP & GLP, Quality Assurance, Orchard Therapeutics
Oct 1013:05
Conference pass

Compliance documentation – does it have to be complicated?

Compliance
Oct 1013:05
Conference pass

Safety and security of AI powered medical devices

Medical Devices
Oct 1013:05
Conference pass

Towards a patient-centric shift: reinventing adherence in tuberculosis care

Patient Centricity
Nibedita Rath, Scientific Director, Open Source Pharma Foundation
Oct 1013:05
Conference pass

Improving mechanistic understanding of adverse events by modelling biological mechanisms

Digital Transformation
Uwe Schühly, Head of Drug Safety and Pharmacovigilance, Santhera Pharmaceuticals
Thomas Nirnberger, Chief Executive Officer, Biofi
Oct 1013:05
Conference pass

Utilising compliance ICSR metrics and PSR for vendor oversight

PV Outsourcing
Melanie Dullemond, PV Compliance Head, Medical and PV Quality, Sanofi
Oct 1014:25
Conference pass

01 Regulatory Agency Panel - Harmonising PV operations across the globe

Artificial Intelligence
Myriam Salem, Pharmacovigilance Manager, Health Canada
Elena Prokofyeva, Head of Drug Safety Unit, DG Post, FAMHP - Federal Agency for Medicines and Health Products in Belgium
Claire Longman, Expert Pharmacovigilance Inspector, MHRA
Oct 1014:25
Conference pass

06 Reserved Panel - TriNetX

Automation

06 Reserved Panel - TriNetX

Oct 1014:25
Conference pass

02 Risk Management Panel – QPPV Oversight for risk management planning and execution

Risk Management
Valentina Mancini, Senior Director, Pharmacovigilance, EU & UK QPPV, Shionogi & TransCelerate
Margherita D'Antuono, EU-UK QPPV, Piramal Critical Care
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Laura Paola Boga, Senior Director, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé Farmaceutici SpA
Oct 1014:25
Conference pass

03 Signal Detection & Management Panel – Integration of real-world data into signal detection activities

Signal Detection & Management
Akhilesh Chamediya, Global Medical Director, Patient Safety Lead, AstraZeneca & Alexion
Tom Organ, Safety Science Director, Neuroscience TA, Global Patient Safety, Ipsen
Oct 1014:25
Conference pass

04 Quality Assurance Panel – Enhancing cross-departmental collaboration for non-interventional studies

Quality Assurance
Valerie Vandevoorde, Executive Director, Global Pharmacovigilance Quality Head, MSD
Jin Vermaat, Vice President, Head of PV Affiliate Relations, Takeda
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Oct 1014:25
Conference pass

05 Compliance Panel – Optimizing PSMFs for inspection findings

Compliance
Rafael Josupeit, EEA QPPV, Procter & Gamble
Nadine Schreiber, Head, Global Pharmacovigilance, Medac GmbH
Monika Manske, Associate Director, Lead Quality Management and Deputy EEA QPPV, Viatris
Balaji Sainath Malla, Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories Inc
Jan Cleerbout, Deputy QPPV, Johnson & Johnson Innovative Medicine
Oct 1014:25
Conference pass

07 Risk Management Panel – Continuous professional training for medicine related stakeholders and patients

Medical Devices
Nathan Rivers, Associate Director, Medical Safety, Oncology, Jazz Pharmaceuticals
Miriam Marotti, Senior Medical Director, Patient Safety Oncology, AstraZeneca
Devi padmanaban, Executive Director, Neurocrine Biosciences
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Oct 1014:25
Conference pass

08 Patient Centricity Panel – What is the impact of shared decision making in patient centricity?

Patient Centricity
Mary Lynne van Poelgeest-Pomfret, President, World Federation for Incontinence and Pelvic Problems (WFIPP)
Mark Daniels, Director, Safety Physician, Jazz Pharmaceuticals
Amit Aggarwal, Executive Director, Medical Affairs & Strategic Partnerships, ABPI
Shaantanu Donde, Senior Medical Director, Head of Portfolio Management Team, Clinical Development & Medical Affairs, Viatris
Oct 1014:25
Conference pass

09 Reserved Panel

Digital Transformation

09 Reserved Panel

Oct 1014:25
Conference pass

10 PV Outsourcing Panel – Evolution of outsourcing: highlights and challenges for vendor management

PV Outsourcing
Kathy Roberts, Vice President, Global Phamacovigilance, Incyte Corp.
Erica Bavol, Senior Director, Head of Safety Operations, Compliance and Systems, Corcept
Eniko Barta Kondas, Head, Global PV Operations, Gedeon Richter PLC
Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, Gsk
Martin Sournac, Manager, Global Pharmacovigilance operations, Incyte
Oct 1015:20
Conference pass

Chair's Remarks

Artificial Intelligence

Chair's Remarks

Oct 1015:20
Conference pass

Chair's Remarks

Automation

Chair's Remarks

Oct 1015:20
Conference pass

Chair's Remarks

Risk Management

Chair's Remarks

Joanna Han, Independent PV Expert
Oct 1015:20
Conference pass
Oct 1015:20
Conference pass

Chair's Remarks

Quality Assurance

Chair's Remarks

Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Oct 1015:20
Conference pass

Chair's Remarks

Compliance

Chair's Remarks

Maha Saad, Associate Vice President, Pharmacovigilance & REMS, Braeburn Pharmaceuticals
Oct 1015:20
Conference pass

Chair's Remarks

Medical Devices

Chair's Remarks

Oct 1015:20
Conference pass

Chair's Remarks

Patient Centricity

Chair's Remarks

Krupa Patel, Senior Safety Scientist, Global Patient Safety, Ipsen
Oct 1015:20
Conference pass

Chair's Remarks

Digital Transformation

Chair's Remarks

Nathalie Joffre, Global Vigilance Director, EU QPPV, Biocodex, Inc.
Oct 1015:20
Conference pass

Chair's Remarks

PV Outsourcing

Chair's Remarks

Barbara Yousif, PV & QA Manager, OnePharmaMedics
Oct 1015:25
Conference pass

Advancing AI for PV professionals

Artificial Intelligence
Oct 1015:25
Conference pass

Automation in ICSRs: managing causality assessments

Automation
Kate Anteyi, Director, Global Safety Physician, Moderna Therapeutics
Oct 1015:25
Conference pass

Harmonizing local activities to improve PV efficiency

Risk Management
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Oct 1015:25
Conference pass

Harmonizing local activities to improve PV efficiency

Risk Management
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Oct 1015:25
Conference pass

First year of competitive safety monitoring of the Pfizer & GSK RSV mass vaccination in the United States

Signal Detection & Management
Lionel Van Holle, Founder, OpenSourcePV
Oct 1015:25
Conference pass

Local and regional divestment: PV collaboration and quality assurance for database transfers

Quality Assurance
Lynne Comiskey, Divestment Coordination Lead, Sanofi
Oct 1015:25
Conference pass

Fostering end to end collaboration between regulatory and safety organisations for RSI

Compliance
Oct 1015:25
Conference pass

Speaker presentation

Medical Devices

Speaker presentation

Oct 1015:25
Conference pass

Sharing is caring – how sharing safety science insights helps affiliate PV teams realize the PV value proposition

Patient Centricity
Vivien Stettner, Director, International PSEQ Strategy & Sights, AbbVie
Oct 1015:25
Conference pass

MHRA: a digital transformation journey

Digital Transformation
Sarah Vaughan, Head of Vigilance Operations, MHRA
Oct 1015:25
Conference pass

Effects of outsourcing on key PV activities: differences from large to small sized pharma

PV Outsourcing

Speaker presentation

Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Oct 1015:45
Conference pass

Sponsor presentation

Automation

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation - Primevigilance

Artificial Intelligence

Sponsor presentation - Primevigilance

Oct 1015:45
Conference pass

Sponsor presentation

Risk Management

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Signal Detection & Management

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Quality Assurance

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Compliance

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

Digital Transformation

Sponsor presentation

Oct 1015:45
Conference pass

Sponsor presentation

PV Outsourcing

Sponsor presentation

Oct 1016:05
Conference pass

AI in predictive safety

Artificial Intelligence

Speaker presentation

Sriram Venkateswaran, Safety Data Science Director, Hoffmann la Roche Ltd
Oct 1016:05
Conference pass

Raising foundational digital dexterity across patient safety

Automation

Sponsor presentation

Mark Widdowson, Senior Manager, Digital Capabilities, WorldWide Patient Safety, Bristol Myers Squibb
Oct 1016:05
Conference pass

Common platforms for education materials in differing geographies

Risk Management
Cristina Hentea, Director, Safety Surveillance and Risk Management, Viatris
Oct 1016:05
Conference pass

Article 20 and JAKi: learnings from a safety physician perspective

Signal Detection & Management
Ivana Vranic, Director, Safety Risk Lead, Inflammation & Immunology, Pfizer
Oct 1016:05
Conference pass

The role of drug safety in due diligences

Quality Assurance
Giovanni Furlan, Director, Worldwide Safety Site Lead, Pfizer
Oct 1016:05
Conference pass

Harmonising PSSFs and fulfilling requirements of local agencies

Compliance
Oct 1016:05
Conference pass

Speaker presentation

Medical Devices

Sponsor presentation

Oct 1016:05
Conference pass

Real world evidence within reverse translation

Patient Centricity
Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche
Oct 1016:05
Conference pass

Digital transformation: small steps versus giant leaps

Digital Transformation
Andrew Moore, Director, PV Operations and Compliance, Takeda
Oct 1016:05
Conference pass

Experiences of outsourcing in critical PV activities: ICSRs processing, aggregate reports and literature reviews

PV Outsourcing

Speaker presentation

Anna Kończak, EU QPPV, Polpharma
Oct 1017:05
Conference pass

Chair's Remarks

Artificial Intelligence

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Automation

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Risk Management

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Signal Detection & Management

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Quality Assurance

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Compliance

Chair's Remarks

Isabella Caramuta, Deputy QPPV, Shionogi BV
Oct 1017:05
Conference pass

Chair's Remarks

Medical Devices

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Patient Centricity

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

Digital Transformation

Chair's Remarks

Oct 1017:05
Conference pass

Chair's Remarks

PV Outsourcing

Chair's Remarks

Oct 1017:10
Conference pass

Advanced automation in case intake: practical guidance and insights

Automation

Speaker presentation

Kristine Mcgraw, Director, Safety Systems and Quality, Erasca, Inc.
Oct 1017:10
Conference pass

How to approach innovation with GenAI in Patient Safety

Artificial Intelligence

Speaker presentation

Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB
Oct 1017:10
Conference pass

Speaker presentation

Risk Management

Speaker presentation

Oct 1017:10
Conference pass

Speaker presentation

Signal Detection & Management

Speaker presentation

Oct 1017:10
Conference pass

PV Down Under: experiences from a TGA inspection

Quality Assurance
Oct 1017:10
Conference pass

Best practices for local PSMF oversight including managing health authority feedback

Compliance

Speaker presentation

Tina Wirstrom, Director, EU QPPV Office, Takeda
Oct 1017:10
Conference pass

Speaker presentation

Medical Devices

Speaker presentation

Oct 1017:10
Conference pass

Vaccine pharmacovigilance in Africa – lessons learnt

Patient Centricity
Oct 1017:10
Conference pass

Speaker presentation

Digital Transformation

Speaker presentation

Oct 1017:10
Conference pass

PV vendors qualifications and their oversight

PV Outsourcing

Speaker presentation

Marianne Banoub, Regional Head of PV and QA, NewBridge Pharmaceutical
Oct 1017:30
Conference pass

Sponsor presentation

Artificial Intelligence

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Automation

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Risk Management

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Signal Detection & Management

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Quality Assurance

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Compliance

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Medical Devices

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Patient Centricity

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

Digital Transformation

Sponsor presentation

Oct 1017:30
Conference pass

Sponsor presentation

PV Outsourcing

Sponsor presentation

Oct 1017:50
Conference pass

Speaker presentation

Artificial Intelligence

Speaker presentation

Oct 1017:50
Conference pass

Speaker presentation

Automation

Speaker presentation

Oct 1017:50
Conference pass

Challenges in creating PV standards across Ukraine and CEE

Quality Assurance

Speaker presentation

Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Oct 1017:50
Conference pass

Speaker presentation

Compliance

Speaker presentation

Oct 1017:50
Conference pass

Speaker presentation

Medical Devices

Speaker presentation

Oct 1017:50
Conference pass

Speaker presentation

Patient Centricity

Speaker presentation

Oct 1017:50
Conference pass

Speaker presentation

Digital Transformation

Speaker presentation

Oct 1017:50
Conference pass

Guidance for successful PV outsourcing

PV Outsourcing

Speaker presentation

Barbara Yousif, PV & QA Manager, OnePharmaMedics
last published: 25/Jul/24 13:06 GMT

Get Involved At World Drug Safety Congress
 

Conference Production


George Mullens
george.mullens@terrapinn.com  
+44 20 8164 3940 

 

Sponsorship & Exhibition Sales


Rohit Dhap
rohit.dhap@terrapinn.com   
+44 20 8164 3001

 

Marketing Opportunities


Karen Duncan
karen.duncan@terrapinn.com